De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Abeona Therapeutics Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Vish Seshadri
Algemeen directeur
US$2.8m
Totale compensatie
Percentage CEO-salaris | 19.5% |
Dienstverband CEO | 3yrs |
Eigendom CEO | 2.1% |
Management gemiddelde ambtstermijn | 3yrs |
Gemiddelde ambtstermijn bestuur | 3.6yrs |
Recente managementupdates
Recent updates
Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?
Sep 23We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
May 01We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
Jan 04Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
Aug 16Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?
Mar 31Abeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder Value
Oct 19Abeona Therapeutics stock continues recent strong run, shares rise ~10%
Oct 04Abeona Therapeutics GAAP EPS of -$2.08, revenue of $1M
Aug 11Abeona therapeutics regains compliance with Nasdaq minimum bid price requirement
Jul 20Abeona crashes 21% as reverse stock split takes effect
Jul 05Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely
Mar 02Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money
Aug 17Abeona Therapeutics shares rise after letter to stockholders
May 26Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt
Apr 28Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)
Feb 21How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 19What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?
Dec 15Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$53m |
Mar 31 2024 | n/a | n/a | -US$77m |
Dec 31 2023 | US$3m | US$555k | -US$54m |
Sep 30 2023 | n/a | n/a | -US$45m |
Jun 30 2023 | n/a | n/a | -US$39m |
Mar 31 2023 | n/a | n/a | -US$31m |
Dec 31 2022 | US$1m | US$505k | -US$43m |
Sep 30 2022 | n/a | n/a | -US$83m |
Jun 30 2022 | n/a | n/a | -US$84m |
Mar 31 2022 | n/a | n/a | -US$91m |
Dec 31 2021 | US$2m | US$255k | -US$85m |
Compensatie versus markt: De totale vergoeding ($USD 2.85M ) Vish } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 1.46M ).
Compensatie versus inkomsten: De vergoeding van Vish is gestegen terwijl het bedrijf verliesgevend is.
CEO
Vish Seshadri (48 yo)
3yrs
Tenure
US$2,847,442
Compensatie
Dr. Vishwas Seshadri, also known as Vish, Ph.D. & M.B.A., serves as Chief Executive Officer, President and Director at Abeona Therapeutics Inc. since October 15, 2021. He served as the Senior Vice Presiden...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 3yrs | US$2.85m | 2.09% $ 5.8m | |
Chief Financial Officer | 2.6yrs | US$1.49m | 0.84% $ 2.4m | |
Senior VP & General Counsel | 4.5yrs | US$1.17m | 0.63% $ 1.8m | |
Senior VP | 3.3yrs | geen gegevens | geen gegevens | |
Vice President of Investor Relations & Corporate Communications | no data | geen gegevens | geen gegevens | |
Chief People Officer | 2.8yrs | geen gegevens | geen gegevens | |
VP & Head of Quality | 3yrs | geen gegevens | geen gegevens | |
Senior VP | 1.1yrs | geen gegevens | geen gegevens | |
Senior Vice President of Regulatory Affairs | no data | geen gegevens | geen gegevens |
3.0yrs
Gemiddelde duur
51yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van ABEO wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 3yrs | US$2.85m | 2.09% $ 5.8m | |
Independent Director | 3.6yrs | US$336.14k | 0.17% $ 467.3k | |
Independent Director | 3.6yrs | US$336.14k | 0.26% $ 734.7k | |
Independent Director | 3.5yrs | US$330.52k | 0.26% $ 739.7k | |
Independent Director | less than a year | geen gegevens | 0.025% $ 71.4k | |
Independent Director | 4.6yrs | US$324.89k | 0.23% $ 629.7k | |
Independent Director | 3.5yrs | US$336.14k | 0.27% $ 764.0k | |
Member of Scientific Advisory Board | 7.5yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 7.5yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 7.5yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 7.5yrs | geen gegevens | geen gegevens | |
Chairman of the Board | 3.6yrs | US$351.14k | 0.33% $ 932.6k |
3.6yrs
Gemiddelde duur
51yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van ABEO wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).